A - Z index

The section presents an alphabetical listing of all pages of the website. Choose a letter from the links below to view all pages with titles that start with that letter. Alternatively view the sitemap, which lists all pages by their topic and placement in the navigation.

• A-Z of herbal medicine ingredients and subjects

• About clinical trials for medicinal products

• About the MHRA speakers

• About us

• Abridged products

• Academic trials: Additional information

• Academic trials: General information

• Access keys

• Access to Yellow Card data

• Active Implantable Medical Devices Directive

• Active Implantable Medical Devices Directive - Complying with requirements

• Active pharmaceutic ingredients (API) - Good Manufacturing Practice: Guidance and legislation

• Active pharmaceutical ingredient (API) FAQs - Good Manufacturing Practice

• Advanced search

• Advanced therapy medicinal products

• Advanced therapy medicinal products advice form

• Advanced therapy medicinal products: Links to relevant websites

• Adverse drug reaction (ADR) reports received by the MHRA from literature articles

• Adverse drug reaction listings

• Adverse drug reactions

• Adverse drug reactions - Healthcare professional reporting

• Adverse drug reactions: Information for the pharmaceutical industry

• Adverse incident reporting for medical devices

• Adverse reactions to medicines, suspected : Reporting of

• Advertising complaint form

• Advertising complaints: Results of investigations

• Advertising investigations

• Advertising of medicines

• Advertising of medicines: The legislative framework

• Advice and information for consumers

• Advice for consumers on using Traditional Chinese Medicines (TCMs)

• Advice notices (devices)

• Advice: Product-specific

• Advisory Board on the Registration of Homeopathic Products

• Advisory Committee on Borderline Substances

• Advisory Committee on Borderline Substances Certificate Request Form

• Agency Board

• Agency Board members

• Agency Board minutes

• Agency Board: Former members

• Agency contacts for swine flu

• Alison Davis, Director of Information Management

• All herbal safety warnings and alerts

• Alpha-adrenoceptor antagonists and intraoperative floppy iris syndrome

• Amendments to your clinical trial authorisation: Additional information

• Amendments to your clinical trial authorisation: Fees

• Amendments to your clinical trial authorisation: What to send

• Aminophylline and theophylline overdose

• Amitriptyline overdose

• Anaesthesia and ventilation

• Anaesthetics - a one-stop resource for anaesthetists

• Anaesthetics: Guidance and publications

• Anaesthetics: Medical Device Alerts

• Anaesthetists: Information for

• Annual report of Committee on Safety of Medicines

• Annual report of the Medicines Commission

• Annual Report on Devices Adverse Incidents

• Annual Report on the regulation of medicines advertising

• Annual Reports and Accounts

• Annual Service Fee

• Anonymised Single Patient Reports

• Anti-infectives, HIV and Hepatology Expert Advisory Group of the Commission on Human Medicines

• Antiepileptics

• Antipsychotic drugs

• Antiretroviral drugs for HIV

• API FAQs - Good Manufacturing Practice

• Appeals (medical devices)

• Application forms for medicines licences

• Applying to conduct a clinical trial: Additional information

• Applying to conduct a clinical trial: Applications requiring expert advice

• Applying to conduct a clinical trial: Fees

• Applying to conduct a clinical trial: General information

• Applying to conduct a clinical trial: What to send

• ARMs: Applications to reclassify medicines consultation letters

• Assistive technology

• Asthma: Long-acting ß₂ agonists

• Availability of medicines

• Availability, prescribing, selling and supplying of medicines

• Availability, prescribing, selling and supplying of medicines: Frequently raised issues